Biora Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Biora Therapeutics

14/08/2023 22:03

* Biora Therapeutics Inc  BIOR.OQ  reported a quarterly
adjusted
loss of $1.47​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of $1.60
per share.
    * Revenue fell 98.1% to $2.00 thousand from a year ago;
analysts
expected $20.00 thousand. 
    * Biora Therapeutics Inc's reported EPS for the quarter was
a loss
of $1.47​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Biora Therapeutics Inc shares had fallen by 10.1% this
quarter and gained 5.1% so far this year.
    * The company reported a quarterly loss of $17.81 million.
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $82.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 09:03 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.60          -1.47          Beat
                                  -1.59          
 Dec. 31 2022      -1.44          -1.64          Missed
 Sep. 30 2022      -1.87          -0.75          Beat